• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性缺氧诱导的肺动脉高压大鼠中与疾病相关的肠道微生物组和代谢组变化

Disease-associated gut microbiome and metabolome changes in rats with chronic hypoxia-induced pulmonary hypertension.

作者信息

Cao Weitao, Wang Luyao, Mo Qiudi, Peng Fang, Hong Wei, Zhou Yumin, Sun Ruiting, Li Haiqing, Liang Chunxiao, Zhao Dongxing, Zheng Mengning, Li Bing, Peng Gongyong

机构信息

State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Department of Respiratory, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

出版信息

Front Cell Dev Biol. 2024 Jul 12;12:1022181. doi: 10.3389/fcell.2024.1022181. eCollection 2024.

DOI:10.3389/fcell.2024.1022181
PMID:39071798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11272533/
Abstract

BACKGROUND

Pulmonary hypertension (PH) is a progressive disease affecting the lung vasculature that is characterized by sustained vasoconstriction and leads to vascular remodeling. The lung microbiome contributes to PH progression, but the function of the gut microbiome and the correlation between the gut microbiome and metabolome remain unclear. We have analyzed whether chronic hypoxia-induced PH alters the rat fecal microbiota.

PURPOSE

We explored hypoxia-induced pulmonary hypertension model rats to find out the characteristic changes of intestinal microorganisms and metabolites of hypoxia-induced pulmonary hypertension, and provide a theoretical basis for clinical treatment.

METHODS

In the current study, a chronic hypoxia-induced PH rat model was used to investigate the role of the gut microbiome and metabolome as a potential mechanism contributing to the occurrence and development of PH. 16S ribosomal ribonucleic acid (16S rRNA), short-chain fatty acid (SCFA) measurements, mass spectrometry (MS) metabolomics analysis and metatranscriptome were performed to analyze stool samples. The datasets were analyzed individually and integrated for combined analysis using bioinformatics approaches.

RESULTS

Our results suggest that the gut microbiome and metabolome of chronic hypoxia-induced PH rats are distinct from those of normoxic rats and may thus aid in the search for new therapeutic or diagnostic paradigms for PH.

CONCLUSION

The gut microbiome and metabolome are altered as a result of chronic hypoxia-induced PH. This imbalanced bacterial ecosystem might play a pathophysiological role in PH by altering homeostasis.

摘要

背景

肺动脉高压(PH)是一种影响肺血管系统的进行性疾病,其特征是持续性血管收缩并导致血管重塑。肺部微生物群促成了PH的进展,但肠道微生物群的功能以及肠道微生物群与代谢组之间的相关性仍不清楚。我们分析了慢性缺氧诱导的PH是否会改变大鼠粪便微生物群。

目的

探索缺氧诱导的肺动脉高压模型大鼠,以找出缺氧诱导的肺动脉高压肠道微生物和代谢产物的特征性变化,为临床治疗提供理论依据。

方法

在本研究中,使用慢性缺氧诱导的PH大鼠模型来研究肠道微生物群和代谢组作为促成PH发生和发展的潜在机制的作用。对粪便样本进行16S核糖体核糖核酸(16S rRNA)、短链脂肪酸(SCFA)测量、质谱(MS)代谢组学分析和宏转录组分析。使用生物信息学方法对数据集进行单独分析并整合以进行综合分析。

结果

我们的结果表明,慢性缺氧诱导的PH大鼠的肠道微生物群和代谢组与常氧大鼠不同,因此可能有助于寻找PH的新治疗或诊断模式。

结论

慢性缺氧诱导的PH导致肠道微生物群和代谢组发生改变。这种失衡的细菌生态系统可能通过改变体内平衡在PH中发挥病理生理作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/07e5ff1cb913/fcell-12-1022181-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/5ce3c706b454/fcell-12-1022181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/70eac8741d0a/fcell-12-1022181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/f3b1ee770c1b/fcell-12-1022181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/d388a2711c5b/fcell-12-1022181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/2f642015cca2/fcell-12-1022181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/dc29be00aece/fcell-12-1022181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/a46d189d9326/fcell-12-1022181-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/07e5ff1cb913/fcell-12-1022181-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/5ce3c706b454/fcell-12-1022181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/70eac8741d0a/fcell-12-1022181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/f3b1ee770c1b/fcell-12-1022181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/d388a2711c5b/fcell-12-1022181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/2f642015cca2/fcell-12-1022181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/dc29be00aece/fcell-12-1022181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/a46d189d9326/fcell-12-1022181-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f375/11272533/07e5ff1cb913/fcell-12-1022181-g008.jpg

相似文献

1
Disease-associated gut microbiome and metabolome changes in rats with chronic hypoxia-induced pulmonary hypertension.慢性缺氧诱导的肺动脉高压大鼠中与疾病相关的肠道微生物组和代谢组变化
Front Cell Dev Biol. 2024 Jul 12;12:1022181. doi: 10.3389/fcell.2024.1022181. eCollection 2024.
2
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension.肠道-肺部轴心在肺动脉高压中的微生物组和代谢组失调。
Microbiol Res. 2022 Dec;265:127205. doi: 10.1016/j.micres.2022.127205. Epub 2022 Sep 21.
3
Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats.与高血压性心力衰竭大鼠相关的肠道微生物群落组成和代谢物的变化。
BMC Microbiol. 2021 May 5;21(1):141. doi: 10.1186/s12866-021-02202-5.
4
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.慢性乙型肝炎感染相关肝病中肠道微生物组和代谢组学的改变及其对外周免疫反应的影响。
Gut Microbes. 2023 Jan-Dec;15(1):2155018. doi: 10.1080/19490976.2022.2155018.
5
Gut Microbiome-Targeted Modulations Regulate Metabolic Profiles and Alleviate Altitude-Related Cardiac Hypertrophy in Rats.肠道微生物组靶向调节可调节代谢谱并减轻大鼠高原相关的心脏肥大。
Microbiol Spectr. 2022 Feb 23;10(1):e0105321. doi: 10.1128/spectrum.01053-21. Epub 2022 Feb 9.
6
Intermittent Hypoxia and Hypercapnia Alter Diurnal Rhythms of Luminal Gut Microbiome and Metabolome.间歇性低氧和高碳酸血症改变肠腔微生物群和代谢组的昼夜节律。
mSystems. 2021 Jun 29;6(3):e0011621. doi: 10.1128/mSystems.00116-21.
7
Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension.肺动脉高压大鼠模型中肠道微生物组和代谢组的变化。
Bioengineered. 2021 Dec;12(1):5173-5183. doi: 10.1080/21655979.2021.1952365.
8
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
9
Quercetin modulates the gut microbiota as well as the metabolome in a rat model of osteoarthritis.槲皮素可调节骨关节炎大鼠模型中的肠道微生物群及代谢组。
Bioengineered. 2021 Dec;12(1):6240-6250. doi: 10.1080/21655979.2021.1969194.
10
Integrated 16S rRNA Gene Sequencing and LC-MS Analysis Revealed the Interplay Between Gut Microbiota and Plasma Metabolites in Rats With Ischemic Stroke.整合 16S rRNA 基因测序和 LC-MS 分析揭示了缺血性脑卒中大鼠肠道微生物群与血浆代谢物的相互作用。
J Mol Neurosci. 2021 Oct;71(10):2095-2106. doi: 10.1007/s12031-021-01828-4. Epub 2021 May 6.

引用本文的文献

1
Gut Microbiome in Pulmonary Arterial Hypertension-An Emerging Frontier.肺动脉高压中的肠道微生物群——一个新兴前沿领域。
Infect Dis Rep. 2025 Jun 9;17(3):66. doi: 10.3390/idr17030066.
2
Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts.肝旁路在病原体相关肺血管疾病发展中的作用:中腔静脉分流和门体分流的影响
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G791-G800. doi: 10.1152/ajpgi.00409.2024. Epub 2025 May 5.

本文引用的文献

1
Systemic Lupus Erythematosus and Pulmonary Hypertension.系统性红斑狼疮与肺动脉高压。
Int J Mol Sci. 2023 Mar 7;24(6):5085. doi: 10.3390/ijms24065085.
2
Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.肺动脉高压患者的肠道微生物组具有促炎作用,且循环微生物代谢物发生改变。
Am J Respir Crit Care Med. 2023 Mar 15;207(6):740-756. doi: 10.1164/rccm.202203-0490OC.
3
The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension.肠道微生物群在肺动脉高压中的作用和机制。
Nutrients. 2022 Oct 13;14(20):4278. doi: 10.3390/nu14204278.
4
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
5
Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan.慢性血栓栓塞性肺动脉高压患者肠道菌群改变及其与炎症的关系:日本单中心观察性研究。
BMC Pulm Med. 2022 Apr 8;22(1):138. doi: 10.1186/s12890-022-01932-0.
6
Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension.肺动脉高压大鼠模型中肠道微生物组和代谢组的变化。
Bioengineered. 2021 Dec;12(1):5173-5183. doi: 10.1080/21655979.2021.1952365.
7
Microbial Regulation of Host Physiology by Short-chain Fatty Acids.短链脂肪酸对宿主生理学的微生物调节作用。
Trends Microbiol. 2021 Aug;29(8):700-712. doi: 10.1016/j.tim.2021.02.001. Epub 2021 Mar 2.
8
-a new functional genus with potential probiotic properties?是否存在具有潜在益生菌特性的新功能属?
Gut Microbes. 2021 Jan-Dec;13(1):1-21. doi: 10.1080/19490976.2021.1875796.
9
Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.基于肠道微生物组和代谢组的网络分析发现非小细胞肺癌患者相关的微生物组生物标志物。
Int J Mol Sci. 2020 Nov 19;21(22):8730. doi: 10.3390/ijms21228730.
10
Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的疾病相关肠道微生物组和代谢组变化。
Nat Commun. 2020 Nov 18;11(1):5886. doi: 10.1038/s41467-020-19701-0.